Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema Navai

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
BJU International|March 24, 2018
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapyChinedu O Mmeje, Cooper R Benson, Graciela M Nogueras-González, et al.
Urologic Oncology|August 5, 2021
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survivalAkshay Sood, Jacob Keeley, Isaac Palma-Zamora, et al.
World Journal of Urology|May 28, 2018
Salvage topical therapy for upper tract urothelial carcinomaAdithya Balasubramanian, Michael J Metcalfe, Gavin Wagenheim, et al.
BJU International|January 23, 2021
Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancerKelly K Bree, Patrick J Hensley, Nathan A Brooks, et al.
BJU International|July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuérinRoberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Urologic Oncology|November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorshipPatrick J Hensley, Zhigang Duan, Kelly Bree, et al.
Clinical Genitourinary Cancer|January 18, 2022
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial CarcinomaMehrad Adibi, Barrett McCormick, Minas P Economides, et al.
World Journal of Urology|March 14, 2019
The role of metastatic burden in cytoreductive/consolidative radical cystectomyRoger Li, Janet E Baack Kukreja, Mohamed A Seif, et al.
The Journal of Biological Chemistry|December 15, 2012
The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al.
Urologic Oncology|January 19, 2020
Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomesVikram M Narayan, Mohamed A Seif, Amy H Lim, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
BJU International|March 24, 2018
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapyChinedu O Mmeje, Cooper R Benson, Graciela M Nogueras-González, et al.
Urologic Oncology|August 5, 2021
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survivalAkshay Sood, Jacob Keeley, Isaac Palma-Zamora, et al.
World Journal of Urology|May 28, 2018
Salvage topical therapy for upper tract urothelial carcinomaAdithya Balasubramanian, Michael J Metcalfe, Gavin Wagenheim, et al.
BJU International|January 23, 2021
Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancerKelly K Bree, Patrick J Hensley, Nathan A Brooks, et al.
BJU International|July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuérinRoberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Urologic Oncology|November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorshipPatrick J Hensley, Zhigang Duan, Kelly Bree, et al.
Clinical Genitourinary Cancer|January 18, 2022
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial CarcinomaMehrad Adibi, Barrett McCormick, Minas P Economides, et al.
World Journal of Urology|March 14, 2019
The role of metastatic burden in cytoreductive/consolidative radical cystectomyRoger Li, Janet E Baack Kukreja, Mohamed A Seif, et al.
The Journal of Biological Chemistry|December 15, 2012
The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al.
Urologic Oncology|January 19, 2020
Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomesVikram M Narayan, Mohamed A Seif, Amy H Lim, et al.
Pageof 11